Symptomatic bacterial vaginosis occurring during pregnancy is a clinical situation requiring prompt management. Treatment is recommended for all symptomatic pregnant women given the association with serious adverse pregnancy outcomes, including premature rupture of membranes, preterm birth, intra-amniotic infection, and postpartum endometritis.
Treatment ApproachAntibiotic therapy is indicated, with multiple evidence-based options shown to be efficacious in this population — the complete regimen, including specific agent selection and full administration details, is provided in the structured protocol.
Clinical GoalCure of bacterial vaginosis: resolution of vaginal symptoms and signs of infection.
BV treatment is recommended for all symptomatic pregnant women because symptomatic BV has been associated with adverse pregnancy outcomes, including premature rupture of membranes, preterm birth, intra-amniotic infection, and postpartum endometritis.
Studies have been undertaken to determine the efficacy of BV treatment among this population, including two trials demonstrating that oral metronidazole was efficacious during pregnancy by using the 250 mg 3 times/day regimen; however, oral metronidazole administered as a 500 mg 2 times/day regimen can also be used.
View source ↗